E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 10/19/2006 in the Prospect News Biotech Daily and Prospect News Convertibles Daily.

NMT Medical files $65 million shelf registration

By E. Janene Geiss

Philadelphia, Oct. 19 - NMT Medical, Inc. filed a $65 million shelf registration in an S-3 filing with the Securities and Exchange Commission.

The registration covers common stock, preferred stock, debt securities and warrants. Securities may be structured as convertibles.

The proceeds will be used for general corporate purposes, including clinical trial costs, research and development expenses, general and administrative expenses and potential acquisitions of companies, products and technologies.

The Boston-based medical technology company makes instruments and implants used in heart surgery.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.